Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$41.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 48 most recent Form 4 transactions.
| $441.8K |
| -1.6% |
| Open the original filing on SEC.gov |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 101,691 | $64.59 | $6.6M | -18.8% | Open the original filing on SEC.gov |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 108,493 | $23.34 | $2.5M | +25.1% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 195,841 | — | — | — | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 96,125 | $63.64 | $6.1M | -18.2% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 99,716 | $63.26 | $6.3M | -15.9% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 195,841 | $23.34 | $4.6M | +45.2% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 95,666 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 270 | $65.31 | $17.6K | <0.1% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 3,102 | $63.64 | $197.4K | -0.7% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 28,796 | $62.66 | $1.8M | -6.2% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 63,498 | $61.99 | $3.9M | -12.0% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 95,666 | $23.34 | $2.2M | +22.1% | Open the original filing on SEC.gov |
| May 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 22,500 | $43.95 | $988.9K | -4.9% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 22,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 22,500 | — | — | +5.2% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20 | $42.66 | $853 | 0.0% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,165 | $41.75 | $299.1K | -1.6% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 56,815 | $41.01 | $2.3M | -11.4% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 64,000 | — | — | +14.8% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 25,098 | $31.46 | $789.6K | -5.5% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 34,902 | $30.55 | $1.1M | -7.1% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 60,000 | $15.46 | $927.6K | +13.9% | Open the original filing on SEC.gov |
| Feb 20 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 60,000 | $30.10 | $1.8M | -12.2% | Open the original filing on SEC.gov |
| Feb 20 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 60,000 | $15.46 | $927.6K | +13.9% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 33,635 | $32.70 | $1.1M | -7.2% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 66,452 | $32.06 | $2.1M | -12.5% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 303,600 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 113,800 | — | — | +27.2% | Open the original filing on SEC.gov |
| Jan 27 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 51,865 | — | — | — | Open the original filing on SEC.gov |
| Jan 27 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 51,865 | $30.10 | $1.6M | -11.0% | Open the original filing on SEC.gov |
| Jan 27 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 51,865 | $15.46 | $801.8K | +12.4% | Open the original filing on SEC.gov |
| Jan 23 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 8,135 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 8,135 | $30.01 | $244.2K | -1.9% | Open the original filing on SEC.gov |
| Jan 23 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 8,135 | $15.46 | $125.8K | +1.9% | Open the original filing on SEC.gov |
| Oct 29, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 27,128 | — | — | — | Open the original filing on SEC.gov |
| Oct 29, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 27,128 | $30.12 | $817.1K | -6.1% | Open the original filing on SEC.gov |
| Oct 29, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 27,128 | $15.46 | $419.4K | +6.5% | Open the original filing on SEC.gov |
| Oct 28, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 92,872 | — | — | — | Open the original filing on SEC.gov |
| Oct 28, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 92,872 | $30.38 | $2.8M | -18.1% | Open the original filing on SEC.gov |
| Oct 28, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 92,872 | $15.46 | $1.4M | +22.2% | Open the original filing on SEC.gov |
| May 5, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 18,924 | $21.05 | $398.4K | -4.3% | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 18,924 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 18,924 | — | — | +4.5% | Open the original filing on SEC.gov |